---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-23-000077"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2023-07-27T23:59:59+00:00"
generated_at: "2026-06-13T00:51:00.015471+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Maravai LifeSciences completes planned CEO succession; Martin becomes CEO, Hull Executive Chairman

## Summary
- William 'Trey' Martin, III named CEO effective July 27, 2023; previously President of Biologics Safety Testing segment.
- Carl Hull transitions from interim CEO to Executive Chairman; annual base salary reduced to $500,000.
- Hull's target annual bonus set at 100% of salary for 2024+; 2023 target remains $757,667.
- Martin's compensation unchanged from his prior role as President of Biologics Safety Testing.

## SEC filing metadata
- accession: 0001823239-23-000077
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2023-07-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000077/0001823239-23-000077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000077/mrvi-20230727.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-23-000077
- JSON: https://secwatch.observer/filing/0001823239-23-000077.json
- Plain text: https://secwatch.observer/filing/0001823239-23-000077.txt

## Key facts
- Executive change
  William 'Trey' Martin, III was appointed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC..
  - Action: assumed
  - Role: Chief Executive Officer
  source text: On July 27, 2023, William “Trey” Martin, III assumed the role of Chief Executive Officer (“CEO”) of Maravai LifeSciences Holdings, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000077/0001823239-23-000077-index.htm
- Executive change
  Carl W. Hull changed role as Executive Chairman at MARAVAI LIFESCIENCES HOLDINGS, INC..
  - Action: ceased
  - Role: Executive Chairman
  source text: Concurrently with the appointment of Mr. Martin as CEO, Carl W. Hull ceased to serve as interim CEO of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000077/0001823239-23-000077-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.